Ascension St. John Medical Center’s Neuroscience Institute in Tulsa, Oklahoma has been recognized as a designated Clinical Center by the Alliance to Cure Cavernous Malformation for the treatment of cavernous malformations. A cavernous malformation, also known as a cerebral cavernous malformation (CCM), angioma or cavernoma, is a raspberry-shaped collection of abnormal blood vessels with thin, leaky walls,…
Researchers at Duke, U of Chicago, and Penn have identified the link between DVAs, commonly found in sporadic patients, and CCM lesions. Read more here.
Alliance to Cure Cavernous Malformation turns 20! To note this milestone, join us for our national virtual Strides to Cure CCM 5k on May 15th! Gather your friends and family to walk, run, or roll wherever you are. Registration is free with a recommended donation of $20 for 20 years. Raise or donate $20 to…
Join us for what will certainly be a fascinating webinar update on neurosurgical advances with Dr. Lawton on April 21, 2022, at 7:30 Eastern Time, 4:30 Pacific Time. Dr. Michael Lawton, is the President and CEO of Barrow Neurological Institute and the Chair of the Department of Neurosurgery. He is board certified by the American…
Dr. Issam Awad, MD, MSc, FACS, founding Chairman of the Alliance to Cure Cavernous Malformation Scientific Advisory Board & John Harper Seeley Professor of Neurosurgery and director of Neurovascular Surgery at the University of Chicago will update the Alliance to Cure Cavernous Malformation community on the Atorvastatin Clinical Trial. The session will conclude with a…
